Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Cancer Chat is our fully moderated forum where you can talk to others affected by cancer, share experiences, and get support. Cancer Chat is free to join and available 24 hours a day.

Findings from an earlier trial of the Eli Lilly drug, called lepodisiran, showed the drug was safe. The latest study, a Phase 2 clinical trial funded by Lilly, included 320 people. One injection ...

A panel of Brazil Supreme Court justices on Wednesday unanimously accepted charges against former President Jair Bolsonaro over an alleged attempt to stay in office after his 2022 election defeat, and ...

The PACIFIC trial only enrolled patients who did not progress during chemoradiation. In practice, some patients may progress before receiving consolidation immunotherapy. Patients with locally ...

There were daylong closing arguments Wednesday in the Charlie Javice fraud trial in New York. Prosecutors allege Javice tricked JPMorgan into buying her financial aid website, Frank, for $175M.

Tesla released a limited FSD trial in China in hopes of boosting sales for the program, which is priced at RMB 64,000 ($8,823.33). However, Tesla customers in China with Enhanced Autopilot (EAP ...

Former Brazilian President Jair Bolsonaro should stand trial on charges related to an alleged plot to overturn the 2022 election results, the country’s Supreme Court has determined. The court on ...

For the 151 patients in the PAPILLON clinical trial who received RYBREVANT ... from the Phase 3 MARIPOSA Study. 2025 European Lung Cancer Congress. March 26, 2025. 2 Johnson & Johnson.

Also during the hearing, the defense asked Cannone to let them argue again during trial that three men were responsible for John O'Keefe's death, not Read. Read is accused of hitting and killing O ...

By Ana Ionova Reporting from Rio de Janeiro Jair Bolsonaro, Brazil’s former president, will face trial on charges that he oversaw a vast scheme to cling to power after losing the 2022 elections ...